![4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine - chemical structure image](https://media.scbt.com/product/4--5-6-7-8-tetrahydro-1-naphthalenyloxy-methyl-piperidine-structure_23_10_b_231045.jpg)
![4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine - chemical structure image](https://media.scbt.com/product/4--5-6-7-8-tetrahydro-1-naphthalenyloxy-methyl-piperidine-structure_23_10_t_231045.jpg "Molecular structure of 4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine")
Molecular structure of 4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine
4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine
Molecular Weight:
245.36
Molecular Formula:
C16H23NO
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Safety Information
SDS & Certificate of Analysis
Cinoxacin is an antibacterial quinolone analog of oxolinic acid. The compound has been documented to block DNA synthesis through inhibition of Topo II (DNA gyrase) as well as topoisomerase IV. Cinoxacin has been observed to block both topoisomerse IV in both prokaryotic and eukaryotic cell lines. Due to the inhibiting activity of Cinoxacin the compound has displayed toxicity against eukaryotic cells. In vitro studies have shown the renal damage caused by Cinoxacin to be attributed to deposition of Cinoxacin crystals in the urinary tract.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-[(5,6,7,8-Tetrahydro-1-naphthalenyloxy)methyl]-piperidine, 500 mg | sc-315291 | 500 mg | $295.00 |